MolNFT v1 · #83502 · protein

Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor

3WK9 · Bifunctional epoxide hydrolase 2: “Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor”. X-ray diffraction, 3 ligands (S0F, MG, PO4), 4 pockets (best druggability 0.79). MolNFT v1 #83502 on GenesisL1…

PDB: 3WK9
Type: protein
Length: 546 residues
Chains: 1
Method: x-ray diffraction
Collection: MolNFT v1 / PDB
Contract: 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner: 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule: Bifunctional epoxide hydrolase 2
EC: 3.3.2.10, 3.1.3.76
UniProt: P34913
Ligands: S0F, MG, PO4
Pockets: 4 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 15% strand (DSSP).

Chain	Molecule	Type	Residues	Secondary structure	UniProt
A	Bifunctional epoxide hydrolase 2 (EC 3.3.2.10, 3.1.3.76)	protein	546	47% helix, 15% strand	P34913

Ligands and binding sites

S0F · 5-(4-bromobenzyl)-1,3-thiazol-2-amine · ligand · chains A
MG · Magnesium ion · metal · chains A
PO4 · Phosphate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

Pocket	Volume (Å³)	Druggability	Buriedness	Lining residues	Inside
1	428	0.79	0.87	31	empty
2	226	0.74	0.89	29	S0F
3	260	0.70	0.85	37	MG, PO4
4	511	0.61	0.75	38	empty

Compared structures

3WK9 · Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
Every structure of UniProt P34913
Elsewhere: RCSB PDB 3WK9 · PDBe 3WK9 · UniProt P34913

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.